ARTICLE | Clinical News
Ixsys regulatory update
January 31, 1994 8:00 AM UTC
Ixsys (San Diego) received U.S. Patent No. 5,264,563 covering the synthesis of random codons that encode amino acids. The technology facilitates the humanization and optimization of monoclonal antibod...